Alembic Pharmaceuticals announces USFDA final approval for Doxycycline Capsules, 40 mg
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
Signs MoUs with Shri Krishna Ayush University and Dabur India
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients
Cipla had earlier invested € 15 million in Ethris in 2022
This is the first peptide product approval from the USFDA received by Alembic Pharmaceuticals
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
HaystackAnalytics is engaged in the business of developing genomic analysis software
Subscribe To Our Newsletter & Stay Updated